Formation and development of a thrombus or blood clot in the blood vessel.
| Excerpt | Reference |
|---|
| "Deep-venous thrombosis is strongly suggested when PVP exceeds 31 cm of saline." | ( Ellwood, RA; Lee, WB, 1979) |
| "Thrombosis is not equivalent to hemostasis, but is a distortion of the hemostatic process." | ( Cooke, AR; Rodvein, R, 1975) |
| "If thrombosis is important in the genesis of atherosclerosis, these findings could indicate that elevation of plasma lipids may play a role, via the coagulation pathway, in the production of human vascular disease." | ( Adel, HN; Clarkson, TB; Deming, QB; Kim, WM; Lofland, HB; Merskey, C; Wolinsky, H, 1976) |
| "In FPE thrombosis is frequent and typically there is eosinophilia." | ( Rossi, E, 1976) |
| "Postoperative thrombosis is four times more likely to occur if oral contraceptives containing oestrogen are used before a major surgical procedure." | ( , 1976) |
| "Vasculitis or thrombosis is not a feature of any of the cases." | ( Sumner, HW; Tedesco, FJ, 1975) |
| "If thrombosis is seen as the final arterial event in virtually all major episodes of IHD, the indications for antithrombotic agents in primary prevention may be wider than those for lipid-lowering regimens." | ( Meade, TW, 1992) |
| "Thrombosis is not only the usual precipitant to a clinical event, but it may also be involved in atherosclerotic plaque development throughout most of the adult years." | ( Bovill, EG; Tracy, RP, 1992) |
| "Intracerebral thrombosis is an uncommon but significant cause of stroke in young adults." | ( Scott, EB, 1992) |
| "Recurrent thrombosis is a potentially serious problem for patients with lupus anticoagulant or anticardiolipin antibodies or both." | ( Brewer, PM; Rosove, MH, 1992) |
| "Bleeding and thrombosis are frequent complications in myeloproliferative disorders (MPD) and are associated with severe organ damage and a high mortality." | ( Daum, I; Jamin, H; Schneider, W; Wehmeier, A, 1991) |
| "Deep vein thrombosis is a serious medical problem that may lead to pulmonary embolus." | ( Alexander, J; Moss, EG, 1990) |
| "Thrombosis is the end result of two closely interrelated processes: the coagulation cascade and the platelet aggregation process." | ( Cooley, BC; Edstrom, LE; Kenna, DM; Khouri, RK, 1990) |
| "Thrombosis is a common sequela of total parenteral nutrition." | ( Cohen, Z; Craig, M; Gotlieb, A; Jeejeebhoy, KN; Levy, GA; Rosenthal, A; Wakefield, A, 1989) |
| "Arterial thrombosis is also associated with multiagent chemotherapy in patients with breast cancer." | ( Korzun, AH; Norton, L; Perloff, M; Rice, MA; Wall, JG; Weiss, RB; Wood, WC, 1989) |
| "In the first model thrombosis is induced in the vena cava by a combination of venous stasis and hypercoagulability; these thrombi consist merely of red cells and fibrin with only a few platelets." | ( Bourgondiën, FG; Hobbelen, PM; Meuleman, DG; Vogel, GM, 1989) |
| "Renal vein thrombosis is a relatively uncommon disease that is being recognized with increasing frequency owing to both modern angiographic techniques and noninvasive modalities such as magnetic resonance imaging and renal images." | ( Petronis, J, 1989) |
| "Renal vein thrombosis is a rare complication of renal transplantation." | ( Kirchner, PT; Myerly, KF, 1988) |
| "Acute thrombosis is usually preceded by prolonged, progressive, ischemia, is less abrupt in onset and occurs most commonly in the superficial femoral artery." | ( McPhail, NV, 1986) |
| "Thrombosis is associated with their inheritance." | ( Di Marzo, V; Erdjument, H; Lane, DA; Morris, HR; Panico, M, 1988) |
| "Bleeding and thrombosis are well known major causes of morbidity and mortality in patients with myeloproliferative disorders (MPD) but the relationship between these clinical events and the commonly found platelet function abnormalities have not been established." | ( Baker, RI; Manoharan, A, 1988) |
| "Although arterial thrombosis is primarily initiated by platelet aggregates forming in vivo, heparin is commonly administered for acute arterial thromboembolism including peripheral arterial occlusion and repeated transient cerebral ischaemic events." | ( Ockelford, P, 1986) |
| "Although arterial thrombosis is initiated by formation of a layer of platelets on modified endothelium or subendothelial constituents and subsequent recruitment of passing-by platelets, this phenomenon is not sufficient to lead to a full thrombus." | ( Fuster, V; Vermylen, J; Verstraete, M, 1986) |
| "Laser-induced thrombosis is inhibited in a dose-dependent way by both drugs." | ( Seiffge, D; Weithmann, KU, 1987) |
| "Atrial thrombosis is a common lesion in female Taconic Swiss mice fed a high-fat (28%), low-protein (8%), hypolipotropic diet for 10 wk or longer." | ( Ashburn, AD; Weaver, M, 1974) |
| "Bleeding and thrombosis are major causes of morbidity and mortality in patients with myeloproliferative disorders." | ( Schafer, AI, 1984) |
| "Acute aortic thrombosis is a rarely described complication of angiography with the technique of arterial catheterization." | ( Kiermayer, H, 1984) |
| "Signs of thrombosis are interruption of blood flow, collateral formation and platelet deposition." | ( Endert, G; Ritter, H; Schumann, E, 1983) |
| "Branch thrombosis is an occlusion of an arterial branch while the main artery driving blood into the limb is normal." | ( Krahenbuhl, B, 1983) |
| "Vascular thrombosis is the response to injury of blood and the vessel wall." | ( Beretz, A; Cazenave, JP; Klein-Soyer, C, 1982) |
| "Upper extremity thrombosis is responsible for 1-2% of all cases of deep venous thrombophlebitis (DVT)." | ( Cordasco, EM; Demeter, SL; Piedad, OH; Pritchard, JS; Taherj, S, 1982) |
| "Rethrombosis is regularly found at all time intervals." | ( Emeis, JJ; van Aken, PJ, 1982) |
| "Risk of vascular thrombosis is apparently multiplied by 11 in OC (oral contraception) users." | ( Beaumont, JL; Beaumont, V, 1981) |
| "Mesenteric vein thrombosis is an abdominal emergency that is rarely diagnosed early." | ( Feuchtwanger, MM; Khodadadi, J; Nacasch, N; Rozencwajg, J; Schmidt, B, 1980) |
| "Thrombosis is an uncommon complication of AIDS, and bilateral subclavian thrombi are rare." | ( Bayer, DD; Condoluci, DV; Sorbello, AF, 1995) |
| "Thrombosis is also frequently induced by velamentous insertion of the cord, as are hemorrhages when the membranous vessels rupture during parturition." | ( Benirschke, K, 1994) |
| "Coronary thrombosis is a dynamic process dependent on the pathological substrate, the local shear forces, and blood factors." | ( Badimon, JJ; Badimon, L; Chesebro, JH; Fallon, JT; Fernández-Ortiz, A; Fuster, V; Mailhac, A; Meyer, B, 1994) |
| "Thrombosis is the most serious acute problem for small diameter arterial bypass grafts." | ( Hall, JD; Rittgers, SE; Schmidt, SP, 1994) |
| "Arterial thrombosis is a rare complication of the nephrotic syndrome, occurring mainly in men." | ( Cormier, F; Cormier, JM; Farkas, JC; Laurian, C; Marzelle, J; Tabet, G, 1993) |
| "Thrombosis is a recognized complication of Hodgkin's disease." | ( Carson, SD; Haire, WD; Pirruccello, SJ, 1994) |
| "Renal vein thrombosis is a rare disease, which most often occurs in the newborn, in premature babies with complicated deliveries, dehydration, septicaemia or congenital heart defects or in neonates delivered by diabetic mothers." | ( Andersen, G; Fisker, RV; Lauridsen, KN, 1993) |
| "In conclusion, LV thrombosis is frequent after thrombolytic therapy for AAMI, and impaired LV wall motion represents an independent predisposing factor." | ( Dale, J; Hegrenaes, L; Kontny, F; Lem, P; Morstøl, T; Søberg, T, 1993) |
| "Acute portal vein thrombosis is rare, but can develop into serious complications." | ( Cramer, B; Kennedy, R; Laishram, H, 1993) |
| "Vascular thrombosis is a common and potentially life-threatening condition, but objective diagnosis is highly desirable before anticoagulant therapy is instituted." | ( Knight, LC, 1993) |
| "If deep venous thrombosis is recognized and treated too late, the consequences are irreversible." | ( Carstensen, G, 1993) |
| "The new thrombosis is often arterial and may carry a grave prognosis." | ( Abildgaard, U; Myhre, HO, 1996) |
| "Vein and arterial thrombosis is a rather rare but potentially life-threatening complication of nephrotic syndrome (n." | ( Cichocka, E; Ksiazek, J; Lukasiewicz, H; Teklińska, E; Wyszyńska, T, 1995) |
| "Mesenteric venous thrombosis is a rare, but potentially lethal, complication of pancreatitis." | ( Cannova, J; Krummen, DM; Schreiber, H, 1996) |
| "The deep vein thrombosis is often neglected, either because it has no clinical expression or because the symptoms it causes regress rapidly with treatment." | ( Bonnet, JL, 1995) |
| "Acute thrombosis is thought to contribute to abrupt coronary occlusion during percutaneous coronary revascularization despite the administration of heparin and aspirin." | ( Eisenberg, PR; Lasala, JM; Oltrona, L; Sewall, DJ; Shelton, ME; Winters, KJ, 1996) |
| "The risk of major thrombosis is higher in ET patients aged more than 60 ys." | ( Barbui, T; Brière, J; Dupuy, E; Finazzi, G; Kiladjian, JJ, 1996) |
| "Bleeding and thrombosis are major causes of morbidity and mortality in patients with chronic myeloproliferative disorders." | ( Carpi, A; Ferretti, A; Nicolini, A; Sagripanti, A, 1996) |
| "However, thrombosis is not sufficiently predictable with standard diagnostic procedures." | ( Heidtmann, HH; Lamparter, S; Schuermann, M, 1997) |
| "Thrombosis is an important limitation of metallic coronary stents, especially in smaller vessels in which shear rates are high." | ( Eigler, NL; Forrester, JS; Ivey, PA; Jordan, RE; Kaul, S; Litvack, F; Makkar, RR; Nakamura, M; Shah, PK, 1997) |
| "Acute graft thrombosis is a severe complication in vascular surgery that may require limb amputation or even cause death." | ( Hach-Wunderle, V; Kainer, K; Müller-Berghaus, G; Pötzsch, B; Salzmann, G, 1997) |
| "Intramural thrombosis is a consistent finding in the arteries of patients who die following coronary angioplasty." | ( Burnand, KG; Gaffney, PJ; Humphries, J; Lattimer, C; McGuinness, CL; Smith, A; Whitton, C, 1997) |
| "Venous thrombosis is a relatively usual but serious complication of permanent transvenous pacing." | ( Hori, M; Ito, T; Iwai, K; Kamada, T; Kato, J; Nishino, M; Tanahashi, H; Tanouchi, J; Yamada, Y, 1997) |
| "Ovarian vein thrombosis is an uncommon, potentially fatal disorder that can be adequately treated with medication." | ( Perquin, DA; Puylaert, JB; Warmerdam, PE; Yedema, CA, 1997) |
| "Thrombosis is a well-recognized complication following insertion of central venous catheters and is associated with significant morbidity." | ( Baglin, T; Bass, G; Boraks, P; Ethell, M; Keeling, D; Mahendra, P; Marcus, R; Price, J; Seale, J, 1998) |
| "Prosthetic valve thrombosis is a well-known condition." | ( Angelini, P; Krajcer, Z; Stainback, RF, 1998) |
| "Arterial thrombosis is considered to arise from the interaction of tissue factor (TF) in the vascular wall with platelets and coagulation factors in circulating blood." | ( Badimon, JJ; Bohrmann, B; Fallon, JT; Giesen, PL; Himber, J; Kling, D; Nemerson, Y; Rauch, U; Riederer, MA; Roqué, M, 1999) |
| "Deep vein thrombosis is a serious complication of orthopaedic surgery and can lead to pulmonary embolism and long term post-thrombotic syndrome." | ( Bergqvist, D; Horst, M; Levin, LA, 1998) |
| "Thrombosis is a pivotal event in the pathogenesis of coronary disease." | ( Arora, R; Bodenheimer, MM; Brown, MW; Case, RB; Dwyer, EM; Gillespie, JA; Goldstein, RE; Greenberg, H; Hochman, J; Krone, RJ; Liang, CS; Lichstein, E; Little, WC; Marcus, FI; Marder, VJ; Moss, AJ; Oakes, D; Sparks, CE; Van Voorhees, L; Watelet, LF; Weiss, HJ; Zareba, W, 1999) |
| "Thrombosis is a key feature of the initiation and progression of atherosclerosis and its clinical sequelae." | ( Camera, M; Colli, S; Toschi, V; Tremoli, E, 1999) |
| "Thrombosis is a major cause of mortality in the industrialized world." | ( Bostrom, LL; Carini, DJ; Ellis, CD; Harrison, K; Huang, PP; Knabb, RM; Liauw, AY; Pruitt, JR; Quan, ML; Thoolen, MJ; Wexler, RR; Wong, PC, 1999) |
| "Thrombosis is a rare complication of APL and may be due to the alterations in hemostasis caused by the disease itself as well as ATRA and antifibrinolytics." | ( Gürsel, T; Kantarci, S; Koçak, U; Oztürk, G, 2000) |
| "Thrombosis is a major complication of human hemolytic anemias such as sickle cell disease, thalassemia, and severe hereditary spherocytosis (HS)." | ( Barker, JE; Tait, JF; Wandersee, NJ, 2000) |
| "Hemorrhage and thrombosis are associated with major vascular and trauma surgery." | ( Armstead, VE; Geary, BT; Nielsen, VG; Opentanova, IL, 2001) |
| "Coronary artery thrombosis is often initiated by abrupt disruption of the atherosclerotic plaque and activation of platelets on the subendothelial layers in the disrupted plaque." | ( Bergmeier, W; Cazenave, JP; Gachet, C; Mokhtari-Nejad, R; Nieswandt, B; Ohlmann, P; Rackebrandt, K; Schulte, V; Zirngibl, H, 2001) |
| "Arterial and venous thrombosis are among the clinical features of Behçet's disease (BD), the pathogenesis of which is not completely understood." | ( Aksu, K; Bayindir, O; Doğanavşargil, E; Gümüşdiş, G; Keser, G; Kitapçioğlu, G; Oksel, F; Ozmen, D; Turgan, N, 2001) |
| "Arterial and venous thrombosis are the most common and clinically relevant events of the so-called antiphospholipid syndrome; they are reported in approximately one third of patients with the antiphospholipid (aPL) antibodies." | ( Finazzi, G, 2001) |
| "Thrombosis is a life-threatening complication that occurs in a subset of patients with heparin-induced thrombocytopenia (HITT)." | ( Arepally, GM; Mayer, IM, 2001) |
| "Thrombosis is an important pathophysiologic component of many cardiovascular diseases." | ( Gerszten, RE; Jaffer, FA; Tung, CH; Weissleder, R, 2002) |
| "Thrombosis is the major mechanism underlying acute complications of atherosclerosis." | ( Ananyeva, NM; Kouiavskaia, DV; Saenko, EL; Shima, M, 2002) |
| "Acute-stent thrombosis is a relatively uncommon complication of coronary artery stenting, however, it is a potentially catastrophic event." | ( Adams, MR; Blake, GJ; Kinlay, S; Rogers, C, 2001) |
| "Thrombosis is of greater overall clinical importance in terms of morbidity and mortality than all of the hemorrhagic disorders combined." | ( Henry, RG; Little, JW; McIntosh, BA; Miller, CS, 2002) |
| "Although venous thrombosis is more common in patients with cancer than in the general population, chemotherapy-induced arterial thrombosis rarely has been reported." | ( Cool, RM; Herrington, JD; Wong, L, 2002) |
| "Venous thrombosis is more frequent than arterial thrombosis; both are rare but can be severe; risk is decreased with minidose pills." | ( Schrub, JC, 1972) |
| "Bioprosthetic valve thrombosis is a rare complication, supporting this approach." | ( Korkolis, DP; Koullias, GJ; Marshalko, SJ; Passik, CS, 2002) |
| "Upper extremity thrombosis is a major complication of central venous catheters implanted for chemotherapy in cancer patients." | ( Buchmüller-Cordier, A; Charlet, V; Decousus, H; Dutrey-Dupagne, C; Fournel, P; Jacquin, JP; Laporte, S; Mille, D; Mismetti, P, 2003) |
| "The risk of venous thrombosis is also higher for preparations containing desogestrel or gestodene (third-generation progestogens) than for those containing levonorgestrel (second-generation progestogens)." | ( Helmerhorst, FM; Rosendaal, FR; Tanis, BC; Van Hylckama Vlieg, A, 2003) |
| "Venous thrombosis is a multifactorial disease, with the pathogenesis involving genetic and environmental risk factors." | ( Dahlbäck, B, 2003) |
| "Large vessel thrombosis is a rare presentation of APL." | ( Goede, A; Kalk, E; Rose, P, 2003) |
| "The risk of major thrombosis is higher in patients with ET who are older than 60 years and who have had a previous occlusive event." | ( Barbui, T; Finazzi, G, 2003) |
| "Arterial thrombosis is initiated following lesion of the vessel wall, either through rupture of an atherosclerotic plaque containing lipids, adhesive proteins and tissue factor or after angioplasty exposing the thrombogenic subendothelial matrix." | ( Cazenave, JP; Gachet, C; Lanza, F; Wiesel, ML, 2003) |
| "Graft thrombosis is an important cause of early (<4 weeks) renal graft loss." | ( Fernando, ON; Hutchinson, C; Koffman, G; Lord, R; Nagra, A; O'Sullivan, C; Rees, L; Taylor, JD; Trompeter, RS, 2004) |
| "Thrombosis is a prominent feature of acute vascular rejection (AVR), the current barrier to survival of pig-to-primate xenografts." | ( Ghanekar, A; Grant, DR; He, W; Levy, GA; Liu, H; Liu, M; Mendicino, M; Phillips, MJ; Zhong, R, 2004) |
| "Intra-pericardial thrombosis is usually due to haemorrhage into the pericardial space or after traumatic pericardiocentesis." | ( Carruthers, DM; Lau, EW; Prasad, N, 2004) |
| "Coronary artery thrombosis is usually triggered by platelet-rich thrombus superimposed on a spontaneously or mechanically disrupted atherosclerotic plaque." | ( Bates, ER, 2004) |
| "Subacute thrombosis is an infrequent but potentially life-threatening complication of percutaneous coronary intervention (PCI) that has received much attention in association with drug-eluting stent (DES) deployment." | ( Foto, D; Medina, RP, 2004) |
| "Thrombosis is an initiating reaction to vascular injury that follows the placement of vascular devices." | ( Edelman, ER; Kolandaivelu, K, 2004) |
| "Dialysis fistula thrombosis is the most common and dangerous complication which prevents proper dialysis therapy." | ( Bojarska-Szmygin, A; Gieryng, J; Janicka, L; Janicki, K; Orłowska, A; Pietura, R, 2003) |
| "It is known that thrombosis is a leading cause of vascular access failure and that the formation of thrombus requires platelets." | ( Chen, CL; Chou, JD; Chou, KJ; Chung, HM; Fang, HC; Hwang, YY; Jan, CR; Lee, PT, 2004) |
| "Atherothrombosis is a pathophysiologic process that results in clinical ischemic events affecting the cerebral, coronary, and peripheral arterial circulation." | ( Anand, SS; Tran, H, 2004) |
| "Arterial thrombosis is associated with endothelial dysfunction." | ( Davis, MR; Dixon, PM; Fitzpatrick, CM; Kashyap, VS, 2004) |
| "Microvascular thrombosis is a prominent feature in cardiac delayed xenograft rejection (DXR)." | ( Byrne, GW; Fass, DN; Kremers, WK; Logan, JS; McGregor, CG; Naziruddin, B; Schirmer, JM; Tazelaar, HD; Teotia, SS; Xu, H, 2005) |
| "Stent thrombosis is associated with considerable morbidity and mortality." | ( Dörffler-Melly, J; Haeberli, A; Hess, OM; Imboden, K; Meier, B; Togni, M; Wenaweser, P; Windecker, S, 2005) |
| "A key factor in thrombosis is tissue factor, a small transmembrane glycoprotein." | ( Mackman, N; Motton, DD; Rutledge, JC; Tilley, RE, 2005) |
| "Arterial thrombosis is a central pathologic mechanism contributing to myocardial infarction and stroke, together the leading causes of death in developed countries." | ( Ginsburg, D, 2005) |
| "Inflammation and thrombosis are key events in the long-lasting sequence of atherosclerotic plaque initiation, plaque growth, and eventual onset of complications leading to clinically manifest disease." | ( de Boer, OJ; Li, X; van der Wal, AC, 2006) |
| "Thrombosis is a rare event in childhood and adolescence." | ( Gunther, G; Merkel, N; Schobess, R, 2006) |
| "Atherothrombosis is associated with the presence of a microinflammatory response, usually monitored by the use of C-reactive protein (CRP) measurements." | ( Ben Assayag, E; Berliner, S; Bornstein, NM; Melamed, S; Rogowski, O; Shapira, I; Shirom, A; Toker, S, 2006) |
| "Inflammation and thrombosis are closely related processes, but the association between disease activity and thrombogenicity in Takayasu's arteritis (TA) is poorly understood." | ( Isobe, M; Kasuya, N; Kishi, Y; Numano, F; Yoshida, M, 2006) |
| "Thrombosis is associated with atherosclerosis, sepsis, cancer, and numerous other inflammatory diseases." | ( Luyendyk, JP; Mackman, N; Tilley, RE, 2006) |
| "Acute in-stent thrombosis is a well-known complication of carotid angioplasty and stenting (CAS) and often due to resistance to or inadequate treatment with platelet-inhibiting agents." | ( Buhk, JH; Knauth, M; Wellmer, A, 2006) |
| "Arterial thrombosis is a critical event in the pathogenesis of lesion development." | ( Chau, LY; Chen, YH; Chiang, MT; Tsai, HL, 2006) |
| "The dangers of thrombosis are well known and yet current therapy presents a paradox; effective methods of pharmacological anticoagulation are available, but underemployed." | ( Donovan, JL; Drake, JA; Tran, MT; Whittaker, P, 2006) |
| "Subacute stent thrombosis is a major clinical concern, and the search for new molecules to cover stents remains important." | ( Akhmedov, A; Baldinger, J; Camici, GG; Lüscher, TF; Matter, CM; Schafer, N; Schulz, U; Shojaati, K; Steffel, J; Tanner, FC; Yang, Z, 2006) |
| "Because arterial thrombosis is the pathophysiologic background of acute coronary syndrome, the possible impact of blocking the arterial thrombosis on its onset is a challenging problem." | ( Blasko, P; Hájek, P; Hrachovinová, I; Malý, MA; Salaj, P; Tomasov, P; Veselka, J, 2007) |
| "Atherothrombosis is a progressive and generalized pathologic process that affects the vascular system." | ( Brown, MT; Kikano, GE, 2007) |
| "Microvascular thrombosis is a key pathophysiologic mechanism during sepsis, ischemia/reperfusion and disseminated intravascular coagulation (DIC)." | ( Hoffmann, JN; Lindenblatt, N; Menger, MD; Rumbaut, RE; Sorg, H; Vollmar, B, 2007) |
| "Thrombosis is not uncommon in children with serious medical conditions." | ( Belvedere, M; Nugent, DJ; Tarantino, MD; Weber, LC; Wohrley, J; Young, G, 2007) |
| "The cause of stent thrombosis is multifactorial, and several stent-related and patient-related variables have been identified." | ( Chen, YD; Jin, ZN; Lu, SZ; Zhao, FH, 2008) |
| "Large vessel thrombosis is a very rare clinical presentation." | ( Foundoulakis, A; Ioannou, CV; Kafetzakis, A; Katsamouris, AN; Koutsopoulos, A; Stavroulaki, E, 2007) |
| "Acute thrombosis is a threat in patients undergoing percutaneous coronary intervention with stent implantation." | ( Badimon, L; Casaní, L; Vilahur, G, 2007) |
| "Venous thrombosis is a well-recognized complication of lenalidomide therapy in patients with multiple myeloma, but its occurrence during the treatment of other hematologic malignancies is less well described." | ( Carwile, J; El Rassi, FA; Tam, CS; Verstovsek, S, 2008) |
| "Stent thrombosis is a feared complication of percutaneous coronary intervention." | ( Di Bella, G; Marte, F; Patanè, S, 2008) |
| "In-stent thrombosis is a rare but potentially devastating complication." | ( Kim, DJ; Lee, KO; Lee, KY; Seo, KD, 2008) |
| "Atherothrombosis is a generalized and progressive process with an inflammatory component." | ( Ellahham, S, 2008) |
| "Right cardiac thrombosis is an infrequent complication after pacemaker implant." | ( Bielli, M; Carola, F; Dellavesa, P; Lanzillo, G; Maffè, S; Paffoni, P; Paino, AM; Pardo, NF; Parravicini, U; Perucca, A; Signorotti, F; Zanetta, M; Zenone, F, 2008) |
| "Atherothrombosis is a major cause of cardiovascular events." | ( Egbrink, MG; Gilio, K; Heemskerk, JW; Heeneman, S; Kuijpers, MJ; Lutgens, E; Nergiz-Unal, R; Nieswandt, B; Prinzen, L; Reitsma, S; van Zandvoort, MA, 2009) |
| "Atherothrombosis is an acute complication that develops on the surface of a ruptured atheromatous plaque or as a consequence of endothelial erosion that may cause myocardial infarction or ischemic stroke." | ( Abu-Fadel, M; Norgard, NB, 2008) |
| "Atrial thrombosis is a relatively rare event in children." | ( Angelini, A; Boriani, G; Bronzetti, G; D'Angelo, C; Picchio, FM, 2009) |
| "In-stent thrombosis is mainly triggered by adenosine diphosphate (ADP)-dependent platelet aggregation after percutaneous coronary stent implantation." | ( Fujimura, Y; Imagawa, K; Jo, J; Kawata, H; Kimura, Y; Matsumoto, M; Saito, Y; Soeda, T; Somekawa, S; Tabata, Y; Takeda, Y; Takemoto, Y; Uemura, S, 2009) |
| "On one hand, thrombosis is one of the key pathophysiologic features of PAH (besides vasoconstriction, proliferation and inflammation)." | ( Kirch, W; Mueller, EA; Opitz, CF; Pittrow, D, 2009) |
| "Spontaneous aortic thrombosis is rare." | ( Mehta, AV; Teixeira, OH, 2009) |
| "Thrombosis is the most frequent clinical manifestation of APS." | ( Chakoutio, V; Ries, F, 2009) |
| "Thrombosis is the second most common cause of death in cancer patients." | ( Khorana, AA, 2009) |
| "Stent thrombosis is a rare but devastating complication of coronary stent implantation." | ( Danenberg, HD; Lotan, C; Marincheva, G; Nassar, H; Varshitzki, B, 2009) |
| "Hemostasis and thrombosis are regulated by agonist-induced activation of platelet integrin alpha(IIb)beta(3)." | ( Alrehani, N; Cruz, MA; Gushiken, FC; Hyojeong, H; Langlois, KW; Pradhan, S; Rumbaut, RE; Vijayan, KV, 2009) |
| "Thrombosis is the common mechanism of various diseases of heart and vasculature and their major morbility and mortality." | ( Gao, YH; Gao, YJ; Hua, X; Li, X; Liu, P; Liu, Z; Tan, KB; Zhou, LN; Zhou, SW, 2010) |
| "Atherothrombosis is considered as an inseparable tangle of platelet activation and coagulation processes, involving plaque components such as tissue factor (TF) and collagen as well as blood-borne TF and coagulation factor XIIa (FXIIa)." | ( Bernlochner, I; Brandl, R; Farndale, RW; Gachet, C; Penz, SM; Ravanat, C; Reininger, AJ; Siess, W; Smethurst, P, 2010) |
| "Thrombosis is still the first cause of microsurgery failure." | ( Dumont, LA; Gangloff, D; Garrido-Stowhas, I; Rongières, M; Tchénio, P, 2010) |
| "Stent thrombosis is a rare but potentially fatal complication of percutaneous treatment of coronary disease." | ( Cassese, S; Chiariello, M; Esposito, G; Gargiulo, G; Piscione, F; Sannino, A; Schiattarella, GG, 2011) |
| "Thrombosis is a common complication of end-stage renal disease, particularly in patients on hemodialysis." | ( Doumas, M; Kambas, K; Kourtzelis, I; Lambris, JD; Magotti, P; Markiewski, MM; Mitroulis, I; Mollnes, TE; Panagoutsos, S; Passadakis, P; Qu, H; Rafail, S; Ritis, K; Vargemezis, V, 2010) |
| "Age and history of thrombosis are the criteria used to stratify patients to the most appropriate therapeutic options." | ( Vannucchi, AM, 2010) |
| "Cancer-associated thrombosis is a major cause of morbidity and mortality." | ( Weitz, JI, 2010) |
| "Animal models of thrombosis are necessary to better understand the complex components and interactions involved in the formation of a clot." | ( Mackman, N; Owens, AP, 2010) |
| "Stent thrombosis is a serious complication of percutaneous coronary intervention (PCI)." | ( Hansen, KN; Jensen, LO; Johnsen, SP; Kaltoft, A; Lassen, JF; Madsen, M; Maeng, M; Ravkilde, J; Sørensen, HT; Thayssen, P; Thuesen, L; Tilsted, HH, 2010) |
| "Thrombosis is characterized by congenital and acquired procatarxis." | ( Arakawa, M; Hagimori, M; Kamiya, S; Ogasawara, M, 2010) |
| "Surface-induced thrombosis is a significant issue for artificial blood-contacting materials used in the treatment of cardiovascular diseases." | ( Ng, MK; Waterhouse, A; Weiss, AS; Wise, SG, 2011) |
| "Late stent thrombosis is very rarely encountered in our patient population, majority Chinese." | ( Chan, KK; Lee, SW; Tam, FC, 2011) |
| "Thrombosis is initiated by tissue factor (TF), a coagulation cofactor/receptor expressed in the vessel wall, on myeloid cells, and on microparticles (MPs) with variable procoagulant activity." | ( Furlan-Freguia, C; Gruber, A; Marchese, P; Ruf, W; Ruggeri, ZM, 2011) |
| "Platelet-mediated thrombosis is a dreaded clinical event and is the primary cause of acute coronary syndromes and post-percutaneous intervention (PCI) ischaemic events." | ( Gurbel, PA; Tantry, US, 2011) |
| "Thrombosis is an important complication; the optimal thromboprophylaxis strategy has not been determined." | ( Andrew, M; Cochrane, A; Hughes, M; Manlhiot, C; McCrindle, BW; Monagle, P; Roberts, R; Szechtman, B; Weintraub, R, 2011) |
| "Thrombosis is a common complication for breast cancer patients receiving chemotherapy." | ( Liaw, PC; Mukherjee, S; Swystun, LL, 2011) |
| "Mechanical valve thrombosis is a rare condition in an adequately anticoagulated patient in the absence of underlying thrombophilia." | ( Cherian, SV; Das, S; Gajra, A; Garcha, AS; Jasti, S; Karachiwala, H, 2011) |
| "Bioprosthetic valve thrombosis is an unexpected complication which has no guidelines for its management." | ( Lengyel, M; Pozsonyi, Z, 2011) |
| "Stent thrombosis is not unusual in a post-operative setting." | ( Agnani, S; Akkus, NI; Rajpal, S, 2012) |
| "Previous thrombosis is an established risk factor for rethrombosis in patients with ET." | ( Cho, KH; Kim, KT; Sohn, SI, 2012) |
| "Atherothrombosis is a leading cause of death in patients with diabetes mellitus." | ( Davì, G; Sestili, S; Vazzana, N, 2012) |
| "Aortic thrombosis is rarely observed in neonates and infants." | ( Krause, U; Paul, T; Schneider, HE; Webel, M, 2012) |
| "Anastomotic thrombosis is one of the leading causes of flap failure; however, there are no validated methods to accurately identify and quantify those patients most at risk of thrombotic complications." | ( Eley, KA; Parker, RJ; Pearson, O; Von Kier, S; Watt-Smith, SR, 2012) |
| "Hemostasis and thrombosis are now increasingly recognized as integrally related to blood rheology and blood flow." | ( Gerace, M; Grabowski, EF; Yam, K, 2012) |
| "Thrombosis is a frequent feature in individuals with myeloma, particularly those treated with oral immunomodulatory drugs (IMID) such as thalidomide or lenalidomide concomitantly with anthracyclines or dexamethasone." | ( Braggio, E; Cesarman-Maus, G; Fonseca, R, 2012) |
| "Additionally, thrombosis is now being increasingly recognized in APL patients and may be associated with ATRA usage." | ( Choudhry, A; DeLoughery, TG, 2012) |
| "Atherothrombosis is the major cause of mortality and morbidity in Western countries." | ( Davì, G; Santilli, F; Vazzana, N, 2012) |
| "Late thrombosis is supposed to be due to a variety of factors, viz." | ( Mazurova, VV; Sukhorukov, OE; Zakharova, OV, 2012) |
| "Stent thrombosis is likely due to incomplete tissue coverage of metallic stents as the contact between metallic stents and blood elements may lead to platelet adhesion and trigger vessel thrombosis." | ( Cabiale, K; Castellino, M; Galloni, MR; Rovere, M; Stolojan, V; Tagliaferro, A; Virga, A, 2013) |
| "Thrombosis is the main cause of failure of small-diameter synthetic vascular grafts when used for by-pass procedures." | ( Baiguera, S; Bianco, A; Del Gaudio, C; Ercolani, E; Galloni, P; Polizzi, L; Santilli, F, 2013) |
| "Thrombosis is an important complication after this procedure." | ( Andrew, M; Cochrane, A; Hughes, M; Manlhiot, C; McCrindle, BW; Monagle, P; Roberts, R; Szechtman, B; Weintraub, R, 2013) |
| "Thrombosis is the cause of mortality in 80% of patients with diabetes mellitus." | ( Akhtar, M; Imran, M; Khan, S; Najmi, AK; Pillai, KK, 2013) |
| "Thrombosis is the second leading cause of death in cancer patients, second only to the cancer itself." | ( Soff, GA, 2013) |
| "Prosthetic valve thrombosis is an uncommon, life-threatening complication that often mandates urgent repeat surgery or thrombolytic therapy." | ( Al Habib, HF; Chu, MW; Diamantorous, P; Tarola, C, 2013) |
| "Detecting aortic thrombosis is important because it is a fatal condition." | ( Ito, S; Nakamura, Y; Noumi, T; Sasaki, Y, 2013) |
| "Arterial thrombosis is a major component of vascular disease, especially myocardial infarction (MI) and stroke." | ( Fisch, AS; Horenstein, RB; Perry, CG; Shuldiner, AR; Stephens, SH, 2013) |
| "Stent thrombosis is one of severe complications after sirolimus-eluting stent implantation." | ( Guo, YL; Li, JJ; Nie, XM; Su, LX; Xu, RX; Zhou, YJ, 2013) |
| "Thrombosis is the major clinical finding in patients with BD, but the cause of the thrombosis is still unclear." | ( Akay, OM; Kaşifoğlu, T; Korkmaz, C; Kuş, G; Yaşar Bilge, NŞ, 2013) |
| "Device thrombosis is a serious complication of CF-LVADs, but its precise prevalence and etiology remains uncertain." | ( Colombo, PC; Duong, J; Garan, AR; Han, J; Jorde, UP; Morrison, KA; Nahumi, N; Naka, Y; Takayama, H; Thomas, S; Uriel, N; Yuzefpolskaya, M, 2014) |
| "Device thrombosis is a multifactorial phenomenon, and differentiation of mechanical and non-mechanical causes is an essential step for individual diagnosis and treatment plans." | ( Colombo, PC; Duong, J; Garan, AR; Han, J; Jorde, UP; Morrison, KA; Nahumi, N; Naka, Y; Takayama, H; Thomas, S; Uriel, N; Yuzefpolskaya, M, 2014) |
| "Secondary microthrombosis is a major pathophysiologic mechanism leading to brain damage following transient mechanical vascular occlusion (TMVO), the most widely used experimental stroke model." | ( Gauberti, M; Martinez de Lizarrondo, S; Orset, C; Vivien, D, 2014) |
| "Thrombosis is one of the major causes of human death worldwide." | ( Darbousset, R; Dignat-George, F; Dubois, C; Mezouar, S; Panicot-Dubois, L, 2014) |
| "Thrombosis is a marker of poor prognosis in individuals with solid tumors." | ( Braggio, E; Cesarman-Maus, G; Fonseca, R; Lome-Maldonado, C; Morales-Leyte, AL, 2014) |
| "Stent thrombosis is a morbid complication after percutaneous coronary intervention." | ( Duraj, L; Fedor, M; Fedorová, J; Galajda, P; Kovář, F; Kubisz, P; Mokáň, M; Samoš, M; Šimonová, R; Staško, J, 2014) |
| "Immunothrombosis is critically supported by neutrophil elastase and the activator molecules of blood coagulation tissue factor and factor XII." | ( Engelmann, B; Massberg, S; Pfeiler, S, 2014) |
| "Atherothrombosis is the main cause of myocardial infarction and ischemic stroke." | ( Cosemans, JM; Feijge, MA; Govers-Riemslag, J; Heemskerk, JW; Kuijpers, MJ; Mattheij, NJ; May, F; Meijers, JC; Renné, T; van der Meijden, PE, 2014) |
| "Left atrial (LA) thrombosis is an important cause of systemic embolization." | ( Furukawa, H; Harada, N; Mawatari, K; Morishima, M; Nakaya, Y; Ohnishi, T; Sakaue, H; Shimohata, T; Takahashi, A; Toda, S; Yasui, S; Yoshioka, E, 2014) |
| "Atherothrombosis is no longer considered solely a disorder of lipoprotein accumulation in the arterial wall." | ( Lüscher, TF; Ridker, PM, 2014) |
| "Thrombosis is a potential significant secondary complication." | ( Jones, S; King, I; Monagle, K; Monagle, P; Newall, F; Weintraub, R, 2014) |
| "Atherothrombosis is a major global public health problem." | ( Steg, G, 2013) |
| "Postoperative thrombosis is associated with aspirin unresponsiveness in this patient population." | ( Baird, CW; Emani, S; Emani, SM; Fynn-Thompson, FE; Pigula, FA; Trainor, B; Zurakowski, D, 2014) |
| "Arterial thrombosis is an important complication of diabetes and cancer, being an important target for therapeutic intervention." | ( Brito, MV; Correia, MT; Cruz, JW; Ferreira, RS; Maffei, FH; Oliva, ML; Ottaiano, TF; Paiva, PM; Salu, BR; Silva, MC, 2014) |
| ": Thrombosis is a major complication that could be fatal in acute or chronic cardio-cerebral-vascular diseases." | ( Lan, T; Quan, ZS; Yu, HL; Zhang, F, 2014) |
| "Thrombosis is rarely reported in cases of afibrinogenemia and is generally associated with thrombophilia or replacement therapy." | ( Chandrakala, S; Ghosh, K; Jadli, A; Mukaddam, A; Patil, R; Shetty, S, 2015) |
| "Arterial thrombosis is the primary cause of most cases of myocardial infarction and stroke, the leading causes of death in the developed world." | ( Oury, C; Rahmouni, S; Senis, YA; Tautz, L, 2015) |
| "Acute thrombosis is the most common mode of stent-graft failure." | ( Anna, M; Cohen, M; Iftikhar, H; Kotev, S; Lim, M; Tayal, R; Wasty, N, 2015) |
| "Atherothrombosis is a term used to describe formation of a thrombus after rupture of an atherosclerotic plaque." | ( Mackman, N; Tatsumi, K, 2015) |
| "Thrombosis is the most common complication of this procedure." | ( Kilic, M; Onal, O; Salman, E; Yetisir, F, 2015) |
| "Thrombosis is a major cause of morbidity and mortality in cancer patients." | ( Falanga, A; Russo, D; Schieppati, F, 2015) |
| "Catheter-related thrombosis is a rare but severe complication in patients treated with prolonged antimicrobial therapy." | ( Desplaces, N; Dubée, V; Ducroquet, F; Guillet, S; Horellou, MH; Marmor, S; Zeller, V; Ziza, JM, 2016) |
| "ESSENTIALS: Thrombosis is a major comorbidity in patients with chronic obstructive pulmonary disease (COPD)." | ( Amore, C; Beume, R; Dell'Elba, G; Di Santo, A; Evangelista, V; Martelli, N; Piccoli, A; Tenor, H; Totani, L, 2016) |
| "Pump thrombosis is a rare but increasingly recognized cause of morbidity and mortality in this population." | ( Cook, J; Kapur, NK; Kiernan, MS; Vest, AR, 2015) |
| "Prosthetic thrombosis is a rare complication, but it has high mortality and morbidity." | ( Accorsi, TA; Avila, WS; Fernandes, JR; Garcez, JD; Lopes, AS; Pomerantzeff, PM; Rosa, VE; Tarasoutchi, F, 2015) |
| "Thrombosis is also the common cause of ischemic heart disease (acute coronary syndrome), stroke, and venous thromboembolism." | ( Ita, K, 2015) |
| "Thrombosis is a necessary physiological process to protect the body from uncontrolled bleeding." | ( Becker, RC; Nimjee, SM; Povsic, TJ; Sullenger, BA, 2016) |
| "Thrombosis is a leading cause of morbidity and mortality." | ( Alexander, W; Hisada, Y; Kasthuri, R; Key, NS; Mackman, N; McNamara, C; Mobarrez, F; Rauch, U; Taylor, A; Voorhees, P; Wallen, H; Witkowski, M, 2016) |
| "Atherothrombosis is a recurrent complication in APS and SLE patients." | ( Aguirre, MA; Barbarroja, N; Collantes-Estevez, E; Cuadrado, MJ; Jimenez-Gomez, Y; López-Pedrera, C, 2016) |
| "The risk of venous thrombosis is particularly high in patients with nephrotic syndrome due to primary membranous nephropathy." | ( Hofstra, JM; Wetzels, JFM, 2016) |
| "Management of thrombosis is based on long-term oral anticoagulation and patients with arterial events should be treated aggressively." | ( Al Marzooqi, A; Al Saleh, J; Khamashta, M; Leone, A, 2016) |
| "Thrombosis is an uncommon, but severe complication of left ventricular assist devices (LVADs)." | ( Dreysse, S; Falk, V; Kaufmann, F; Krabatsch, T; Kretzschmar, A; Müller, M; Pergantis, P; Pieri, M; Potapov, EV; Scandroglio, AM, 2016) |
| "Thrombosis is the leading cause of mortality globally." | ( Fujikawa, A; Fujimura, S; Hosojima, M; Ishiyama, Y; Kadowaki, M; Kawakami, T; Kubota, M; Saito, A, 2016) |
| "Thrombosis is a leading cause of morbidity and mortality throughout the world." | ( Choi, JH; Kim, S, 2017) |
| "Infection and thrombosis are the two leading complications associated with blood contacting medical devices, and have led to the development of active materials that can delivery antibiotics or antithrombotic agents." | ( Brainard, BM; Goudie, MJ; Handa, H; Schmiedt, CW, 2017) |
| "Thrombosis is a devastating complication after repair of traumatic vascular injury." | ( Benjamin, E; Byerly, S; Cho, J; Demetriades, D; Inaba, K; Lam, L; Rowe, V; Wang, E, 2016) |
| "Thrombosis is common in Behçet's Syndrome (BS), and there is a need for better biomarkers for risk assessment." | ( Ahnström, J; Ambrose, NL; Brogan, PA; Eleftheriou, D; Haskard, DO; Johns, M; Khan, E; Kiprianos, AP; Laffan, MA; Mason, JC; Stanford, MR, 2016) |
| "Acute venous thrombosis is prevalent and potentially fatal." | ( Cui, C; Fan, Q; Hu, X; Jian, C; Ma, H; Qi, B; Shou, K; Wu, J; Yang, Z; Yu, A; Zhao, Y, 2017) |
| "Thrombosis is a common complication of chronic kidney disease (CKD), but the causes and mechanisms of CKD-associated thrombosis are not well clarified." | ( Chen, F; Chen, M; Chen, S; Du, C; He, T; Hu, M; Li, F; Shen, M; Su, Y; Wang, J; Wang, S; Wang, X; Xu, Y; Yang, K; Zhao, J, 2017) |
| "Intracardiac thrombosis is a rare complication of Behçet's disease (BD), which may manifest as intracardiac tumor." | ( Abdou, A; Atmani, N; Bamous, M; Boulahya, A; Houssa, MA; Moutakiallah, Y; Nya, F; Seghrouchni, A, 2017) |
| "Thrombosis is a leading cause of death and disability worldwide, and anticoagulants are the mainstay of its prevention and treatment." | ( Harenberg, J; Weitz, JI, 2017) |
| "Thrombosis is a main cause of acute cardiovascular events, and detecting thrombi in small arteries via noninvasive imaging remains challenging." | ( Fan, Q; Fu, C; Li, B; Ma, G; Yao, Y, 2017) |
| "Thrombosis is associated with increased morbidity and mortality in pediatric patients undergoing cardiac surgery." | ( DiNardo, JA; Emani, S; Emani, SM; Mulone, M; Trenor, CC; Zurakowski, D, 2017) |
| "Cancer-associated thrombosis is one of the major causes of worse prognosis among tumor-bearing patients." | ( Almeida, VH; Bozza, PT; Gomes, FG; Hottz, ED; Leal, AC; Monteiro, RQ; Rodrigues, JCF; Rondon, AMR; Sandim, V; Succar, BB; Verçoza, BRF; Zingali, RB, 2017) |
| "Thrombosis is one of the biggest obstacles in the clinical application of small-diameter tissue-engineered blood vessels (TEBVs)." | ( Guan, G; Huo, D; Li, G; Li, Y; Liu, G; Wang, Y; Wei, K; Yang, J; Yang, M; Zeng, L; Zeng, W; Zhu, C, 2017) |
| "Thrombosis is the leading cause of death in patients with cardiovascular disease in the world." | ( Gu, J; Huang, W; Ji, C; Ma, L; Niu, H; Qin, C; Wang, H; Wei, Z; Xin, G; Xing, Z; Zheng, H, 2018) |
| "Thrombosis is the defining feature of the most prevalent causes of cardiovascular mortality, such as myocardial infarction, stroke, and pulmonary artery embolism." | ( Afonyushkin, T; Binder, CJ; Obermayer, G, 2018) |
| "Although thrombosis is a result of activated blood coagulation, no explanation is being offered for the persistent presence of fibrin deposits in the affected organs." | ( Kieliszek, M; Lipinski, B, 2018) |
| "Thrombosis is a major cause of morbidity and mortality in Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs), clonal disorders of hematopoiesis characterized by activated Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling." | ( Adams, D; Castellano, CA; Chappell, RJ; Cherpokova, D; DeAngelo, DJ; Ebert, BL; Galinsky, I; Genovese, G; Hultman, C; Iliadou, B; Martinod, K; McCarroll, SA; McConkey, M; Mullally, A; Neuberg, D; Padera, RF; Schneider, RK; Sellar, RS; Silver, AJ; Steensma, DP; Stone, RM; Wadleigh, M; Wagner, DD; Wolach, O, 2018) |
| "Their role in thrombosis is incompletely understood." | ( Czermak, T; Eberle, C; Ehrlich, A; Gaitzsch, E; Grommes, J; Horst, D; Ishikawa-Ankerhold, H; Mannell, H; Margraf, A; Massberg, S; Nieswandt, B; Novotny, J; Petzold, T; Pircher, J; Saha, P; Schulz, C; Smith, A; Soehnlein, O; Sperandio, M; Stark, K; Stocker, T; Titova, A; Walzog, B; Weckbach, LT, 2018) |
| "Formation of thrombosis is mainly associated with dysfunctions of endothelial cells." | ( Chen, Y; Dong, P; Duan, Y; Gao, X; Han, J; Li, Q; Li, X; Qian, K; Wang, Y; Wei, Z; Yang, X; Zhang, S; Zhao, B; Zhao, D; Zhu, Y, 2018) |
| "Inflammation and thrombosis are involved in the development and progression of sepsis." | ( Cao, Y; Li, D; Wu, WKK; Xia, Y; Yao, R; Yu, H; Yu, J; Zeng, Z; Zhang, L; Zhou, Y, 2018) |
| "Stent thrombosis is infrequent in patients receiving DAPT with ticagrelor or prasugrel." | ( Abu-Assi, E; Alexopoulos, D; Ariza-Solé, A; Autelli, M; Baz-Alonso, JA; Boccuzzi, G; Caneiro Queija, B; Cequier, Á; Cerrato, E; Cespón Fernández, M; Cobas Paz, R; D'Ascenzo, F; Domínguez-Rodríguez, A; Durante, A; Fernández-Barbeira, S; Flores Blanco, P; Gaita, F; Gallo, D; Garay, A; Gili, S; Grosso, A; Íñiguez-Romo, A; Kinnaird, T; Magnani, G; Manzano-Fernández, S; Montabone, A; Morbiducci, U; Muñoz Pousa, I; Quadri, G; Raposeiras-Roubín, S; Rognoni, A; Taha, S; Templin, C; Tommassini, F; Valdés, M; Varbella, F; Velicki, L; Xanthopoulou, I, 2019) |
| "Thrombosis is the most frequent complication." | ( Ascaso, M; Pereda, D; Quintana, E; Sandoval, E, 2019) |
| "Arterial thrombosis is increasingly recognized in children and is mostly related to the presence of an arterial catheter or an ischemic stroke." | ( Albisetti, M; Rizzi, M, 2018) |
| "CIA thrombosis is considered a possible complication of nephroureterectomy, particularly with the pluck technique in open surgery." | ( Ando, T; Katagiri, A; Mizusawa, T; Nakayama, R, 2018) |
| "Risk of thrombosis is higher in JAK2-mutated ET." | ( Barbui, T; Tefferi, A, 2019) |
| "Stent thrombosis is a serious complication after percutaneous coronary intervention and femoropopliteal endovascular intervention." | ( Honda, Y; Kamisato, C; Morishima, Y, 2019) |
| "Arterial thrombosis is triggered by tissue factor, which is a transmembrane glycoprotein can be released into the blood circulation after plaque rupture." | ( Kawamura, M; Shinozawa, E, 2018) |
| "Thrombosis is a shared perpetrating event in the pathophysiology of several cardiovascular disorders such as ischemic stroke, venous thromboembolism, atherosclerosis, and myocardial infarction." | ( Arjmand, S; Forootanfar, H; Khazaeli, P; Pardakhty, A, 2018) |
| "Inflammation and thrombosis are integrated, mutually reinforcing processes, but the interregulatory mechanisms are incompletely defined." | ( Abdeen, S; Abu-Fanne, R; Bdeir, K; Cines, DB; Higazi, AA; Higazi, M; Litvinov, RI; Maraga, E; Mukhitov, AR; Nagaswami, C; Stepanova, V; Weisel, JW, 2019) |
| "Complete graft thrombosis is the leading cause of early graft loss following pancreas transplantation." | ( Baranski, AG; Braat, AE; de Fijter, JW; Huurman, VAL; Kopp, WH; Lam, HD; Schaapherder, AF; van Leeuwen, CAT, 2019) |
| "Mesenteric vein thrombosis is a rare presentation of spontaneous HIT syndrome." | ( Forman, DA; Mohanty, E; Nazir, S; Sheppard, JI; Warkentin, TE, 2019) |
| "Arterial thrombosis is their most devastating complication." | ( Baley-Spindel, I; Dávila-Díaz, R; Márquez-Espriella, C; Rivera-Salgado, MI; Villaseñor-Villalpando, E, 2020) |
| "Thrombosis is more frequent in male patients with active disease and represents an important cause of morbidity and mortality." | ( Becatti, M; Bettiol, A; Emmi, G; Fiorillo, C; Hatemi, G; Prisco, D, 2019) |
| "The acute in-stent thrombosis is an extremely rare complication of CAS especially when it occurs postprocedurally during the first 24 hours." | ( Blažević, N; Jovanović, I; Ljevak, J; Poljaković, Z; Radoš, M; Starčević, K; Toljan, K, 2019) |
| "Cardiovascular thrombosis is responsible a quarter of deaths annually worldwide." | ( Alcaide Corral, C; Andrews, JPM; Dweck, MR; Hadoke, PWF; Lucatelli, C; Macaskill, MG; MacNaught, G; Newby, DE; Portal, C; Tavares, AAS; Walton, T; Wilson, I; Wilson, S, 2020) |
| "Very late stent thrombosis is an infrequent yet potentially fatal complication associated with drug-eluting stents." | ( Intskirveli, N; Nakashidze, I; Patsia, L; Ratiani, L, 2019) |
| "Renal allograft thrombosis is an important cause of early renal allograft loss." | ( Al Midani, A; Fidan, K; Kessaris, N; Marks, SD; Matthias, M; Nagra, A; Ridout, D; Rudarakanchana, N; Tugtepe, H, 2020) |
| "Thrombosis is a pathological coagulation process and can lead to many serious thrombotic diseases." | ( Bai, N; Chen, C; Chen, P; Fu, H; Guo, Y; Lam, YPY; Li, M; Li, W; Malhotra, S; O'Connor, PB; Wu, Q; Zhang, D, 2019) |
| "Arterial thrombosis is extremely rare in early breast cancer patients receiving adjuvant chemotherapy." | ( Choi, YJ; Jang, LC, 2019) |
| "Pump thrombosis is a serious left ventricular assist device complication, though there are no guidelines regarding its treatment." | ( Booth, K; Bouzas-Cruz, N; Ferrera-Durán, C; Gonzalez-Fernandez, O; Jungschleger, J; MacGowan, GA; Parry, G; Robinson-Smith, N; Schueler, S; Shah, A; Tovey, S; Woods, A, 2020) |
| "SIGNIFICANCE: Thrombosis is a threat to human health, and there is an urgent need for new drug." | ( Li, J; Li, S; Liu, X; Ma, N; Qin, Z; Yang, Y, 2020) |
| "Thrombosis is one of the main complications of endovascular treatment for unruptured intracranial aneurysms (UIA)." | ( Chung, J; Lee, D; Lee, DH; Park, JC; Sheen, JJ; Shin, JH; Song, Y; Suh, DC, 2021) |
| "Thrombosis is a major cause of mortality in patients with myeloproliferative neoplasms (MPNs), though there is currently little to offer patients with MPN beyond aspirin and cytoreductive therapies such as hydroxyurea for primary prevention." | ( Brooks, S; Chang, X; Craver, BM; Fleischman, AG; Hoang, S; Lai, HY; Mendez Luque, LF; Ramanathan, G, 2020) |
| "Thrombosis is a principle cause of cardiovascular disease, the leading cause of morbidity and mortality worldwide; however, the conventional anti-thrombotic approach often leads to bleeding complications despite extensive clinical management and monitoring." | ( Chen, J; Duan, L; Wang, J; Wang, Y; Wu, H; Xu, F; Zhang, F; Zhang, T; Zhang, Y, 2020) |
| "Arterial thrombosis is less likely to occur with the use of oral contraceptive pills in the absence of cardiovascular risk factors." | ( Adam, M; Al-Suwaidi, J; Aljundi, A; Khir, F; Mohsen, MK; Rahhal, A, 2020) |
| "Stent thrombosis is considered a multifactorial problem that mostly occurs due to clopidogrel resistance." | ( Cao, SP; Zheng, P; Zhong, HL; Zhou, MC, 2020) |
| "Platelet thrombosis is the main pathogeny resulting in the low curability of ischemic stroke, a leading cause of mortality and disability worldwide." | ( Chen, Z; He, Y; Huang, W; Ji, C; Lee, KH; Li, S; Li, Y; Ming, Y; Morris-Natschke, SL; Niu, H; Wei, Z; Xin, G; Xing, Z; Yang, X; Yu, K; Zhang, B; Zhang, J; Zhang, X, 2020) |
| "Thrombosis is a severe and frequent complication of heparin-induced thrombocytopenia (HIT)." | ( Badiei, N; Brown, MR; Hambly, RJ; Hawkins, K; Rauova, L; Thomas, BR; Thornton, CA; Weisel, JW; Williams, PR, 2020) |
| "While pulmonary thrombosis is a major morbidity associated with hemolytic disorders, the etiological mechanism underlying hemolysis-induced pulmonary thrombosis remains largely unknown." | ( Bennewitz, MF; Brzoska, T; Gladwin, MT; Neal, MD; Ragni, MV; Sundd, P; Tutuncuoglu, E; Vats, R; Watkins, SC, 2020) |
| "Thrombosis is a leading cause of death worldwide." | ( Alves, NJ; Nallan Chakravarthula, T; Zeng, Z, 2020) |
| "Thrombosis is a potentially life-threatening nephrotic syndrome (NS) complication." | ( Agrawal, S; Chanley, MA; Kerlin, BA; Kino, J; Smoyer, WE; Waller, AP; Wolfgang, KJ, 2020) |
| "Surface-induced thrombosis is problematic in blood-contacting devices composed of silicones or polyurethanes (PUs)." | ( Grunlan, MA; Jain, A; Johnson, JC; Lim, KK; Ngo, BKD, 2020) |
| "Thrombosis is rare as the valves get endothelialized early on, and, hence, anticoagulation is not recommended beyond 6 months after valve replacement." | ( Agnihotri, A; Hegde, S; Maysky, M; Rahban, Y, 2020) |
| "Thrombosis is another frequent manifestation of Covid-19 that contributes to poor outcomes." | ( Dofferhoff, ASM; Janssen, R; Janssens, W; Vermeer, C; Visser, MPJ; Walk, J, 2021) |
| "Occlusive thrombosis is a central pathological event in heart attack, stroke, thromboembolism, etc." | ( Firlar, E; Li, O; Li, W; Miyazawa, K; Pendekanti, T; Razmi, A; Sen Gupta, A; Shokuhfar, T; Sun, M; Yang, S, 2020) |
| "Fontan circuit thrombosis is a significant cause of early postoperative morbidity and mortality." | ( Anderson, BR; Ankola, AA; Bacha, EA; Choudhury, TA; Corda, R; Rochelson, E; Smerling, AJ, 2021) |
| "Graft thrombosis is a well-recognised complication of solid organ transplantation and is one of the leading causes of graft failure." | ( Hanley, J; Hoather, TJ; Surianarayanan, V; Thompson, ER; Tingle, SJ; Wilson, CH, 2021) |
| "Neonatal thrombosis is a frequently encountered complication in a neonatal intensive care unit." | ( Bierings, M; Huisman, A; Steenman, F; Vijlbrief, DC, 2021) |
| "Thrombosis is a major complication of cardiovascular disease, leading to myocardial infarction, acute ischemic stroke, or venous thromboembolism." | ( Alkarithi, G; Ariëns, RAS; Duval, C; Macrae, FL; Shi, Y, 2021) |
| "Thrombosis is the pathological basis of cardiovascular and cerebrovascular diseases, which seriously threaten human life and health." | ( Chen, X; Fu, W; Huang, W; Ji, C; Li, S; Li, Y; Ming, Y; Niu, H; Sun, Q; Wei, Z; Xin, G; Yuan, J; Zhao, W; Zhu, Y, 2021) |
| "Coronary artery thrombosis is the major risk associated with Kawasaki disease (KD)." | ( Alber, M; Burns, JC; Grande Gutiérrez, N; Kahn, AM; Marsden, AL; Mathew, M; McCrindle, BW, 2021) |
| "Thrombosis is a major comorbidity of obesity and type-2 diabetes mellitus (T2DM)." | ( Blindauer, CA; Hierons, SJ; Marsh, JS; Stewart, AJ; Wu, D, 2021) |
| "Cancer-associated thrombosis is the second-leading cause of mortality in patients with cancer and presents a poor prognosis, with a lack of effective treatment strategies." | ( Cao, W; Khadka, D; Kim, HJ; Kwak, TH; Lee, SB; Lee, SH; Oh, GS; Park, BO; Shim, H; So, HS; Yoon, CH; Zhu, MY, 2021) |
| "Vein thrombosis is one of the most serious types of cardiovascular disease." | ( Chen, C; Li, X; Mao, C; Tan, K; Tao, Y; Wan, M; Wu, Z; Zhou, M, 2022) |
| "Spontaneous venous thrombosis is often the first clinical sign of cancer, and it is linked to a worsened survival rate." | ( Crescence, L; Dubois, C; Langiu, M; Mege, D; Palacios-Acedo, AL; Panicot-Dubois, L, 2022) |
| "Inflammation and thrombosis are closely intertwined in numerous disorders, including ischemic events and sepsis, as well as coronavirus disease 2019 (COVID-19)." | ( Ebeyer-Masotta, M; Eichhorn, T; Fischer, MB; Lauková, L; Semak, V; Weber, V; Weiss, R, 2022) |
| "Inhibiting thrombosis is a cornerstone of vascular protection." | ( Al-Omran, M; Bhatt, DL; Choi, R; Eikelboom, JW; Heffernan, M; Teoh, H; Verma, S, 2021) |
| "Thrombosis is a common disorder with a relevant burden of morbidity and mortality worldwide, particularly among elderly patients." | ( Argento, FR; Bagni, G; Becatti, M; Bettiol, A; Emmi, G; Fini, E; Fiorillo, C; Galora, S; Mattioli, I, 2022) |
| "Thrombosis is one of the most important pathogenic factors related to cardiovascular diseases." | ( Guo, R; Li, N; Sheng, R; Sun, X; Wang, J, 2023) |
| "Thrombosis is a major cause of morbidity and mortality worldwide." | ( Chen, S; Fang, C; Huang, L; Li, H; Li, L; Liu, Y; Lv, K; Qiao, J; Tang, Z; Wang, H; Wang, J; Wang, X; Xu, X; Yao, G; Zhang, L; Zhang, Y; Zheng, G, 2023) |
| "Still, thrombosis is fatal for the survival of the flaps." | ( Cai, Y; Cao, Z; Han, S; Han, W; Ran, J; Song, C; Wang, Y; Wei, Z; Xie, D; Zhang, H; Zhang, X; Zou, H, 2022) |
| "Thrombosis is one of the feared complications contributing to death in patients with cardiovascular diseases." | ( An, D; Ding, Y; Guo, W; Huang, R; Jiang, Z; Li, Y; Miao, W; Xiong, J; Zhou, M, 2022) |
| "Thrombosis is a common disease that poses a great threat to life and health." | ( Fang, N; Guo, D; Hu, L; Liu, J; Luo, Y; Ran, H; Wang, J; Xu, J; Xu, L; Zhang, W; Zhang, Y; Zhou, J, 2022) |
| "Thrombosis is a common disease that poses a great threat to life and health." | ( Fang, N; Guo, D; Hu, L; Liu, J; Luo, Y; Ran, H; Wang, J; Xu, J; Xu, L; Zhang, W; Zhang, Y; Zhou, J, 2022) |
| "Thrombosis is a common disease that poses a great threat to life and health." | ( Fang, N; Guo, D; Hu, L; Liu, J; Luo, Y; Ran, H; Wang, J; Xu, J; Xu, L; Zhang, W; Zhang, Y; Zhou, J, 2022) |
| "Thrombosis is frequently manifested in critically ill patients with systemic inflammation, including sepsis and COVID-19." | ( Brubaker, LS; Cebula, A; Cruz, MA; Lam, FW; Loor, M; Martinez-Vargas, M; Rosengart, TK; Rumbaut, RE; Seshadri, N; Yee, A, 2023) |
| "Thrombosis is frequently manifested in critically ill patients with systemic inflammation, including sepsis and COVID-19." | ( Brubaker, LS; Cebula, A; Cruz, MA; Lam, FW; Loor, M; Martinez-Vargas, M; Rosengart, TK; Rumbaut, RE; Seshadri, N; Yee, A, 2023) |
| "Aberrant thrombosis is a common feature of systemic conditions like diabetes and obesity, and chronic inflammatory diseases like atherosclerosis, cancer, and autoimmune diseases." | ( Alfar, HR; Aronova, M; Joshi, S; Leapman, RD; Lykins, J; Pokrovskaya, I; Prakhya, KS; Smith, AN; Storrie, B; Whiteheart, SW; Zhang, M, 2023) |
| "A high risk of thrombosis is seen in patients with newly diagnosed multiple myeloma (NDMM), particularly those treated with immunomodulatory drugs (IMiDs)." | ( Lan, T; Li, J; Li, P; Liu, P; Maihemaiti, A; Ren, L; Wang, P; Wang, W; Wang, Y; Xu, B; Xu, J; Xu, T; Yang, Y; Zhou, C, 2023) |
| "Thrombosis is a key pathological event in cardiovascular diseases and is also the most important targeting process for their clinical management." | ( Lan, C; Li, L; Liao, D; Lu, H; Mei, J; Sun, H; Tang, Y; Wang, N; Wang, Y; Wei, M; Wu, T; Xu, K; Zhu, H, 2023) |
| "Arterial thrombosis is the main underlying mechanism of acute atherothrombosis." | ( Beer, JH; Bonetti, NR; Camici, GG; Cooley, BC; Gobbato, S; Jouppila, AS; Lassila, RP; Liberale, LL; Lüscher, TF; Pasterk, L; Saeedi Saravi, SS, 2023) |
| "Thrombosis is the leading cause of death in many diseased conditions." | ( Smith, BC; Yang, M, 2023) |
| "Carotid artery thrombosis is the leading cause of stroke." | ( Gao, W; He, F; Hou, W; Lan, Y; Li, J; Liu, S; Yang, B; Zhang, J; Zhou, M, 2023) |